U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938165) titled 'The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease' on April 10.
Brief Summary: This clinical study evaluates the safety and efficacy of fecal microbiota transplantation (FMT) in patients with steroid-refractory graft-versus-host disease (GVHD).
Study Start Date: April 27, 2020
Study Type: INTERVENTIONAL
Condition:
GVHD
Intervention:
OTHER: Fecal Microbiota Transplant (FMT)
FMT in patients with refractory GVHD
Recruitment Status: COMPLETED
Sponsor: Nanfang Hospital, Southern Medical University
Published by HT Digital Content Services with permission from Health Da...